Katie Demarsh News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Psilera Welcomes Biopharma Executive Dr Magali Haas to its Board of Directors

/PRNewswire/ Psilera, a leading biotechnology company developing groundbreaking therapies for hard-to-treat neurological disorders, is pleased to announce.

Magali haasKatie demarshChris witowskiPrnewswire psileraBrain health nexusCohen veterans bioscience

Psilera Announces Lead Indication for PSIL-006: Behavioral Variant Frontotemporal Dementia (bvFTD)

Psilera Announces Lead Indication for PSIL-006: Behavioral Variant Frontotemporal Dementia (bvFTD)
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Katie demarshChris witowski

Psilera Awarded Tampa Bay HealthTech Company of the Year and Finalists for Company to Watch by GrowFL

Psilera Awarded Tampa Bay HealthTech Company of the Year and Finalists for Company to Watch by GrowFL
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesTampa bayChris witowskiKatie demarshFlorida companies to watchCompany toTampa bay inno awardsTampa bay business journalBay areaPsilera thirdAnnual florida companiesWatch awardsPsilera third eye

Psilera Receives Allowance on Flagship Patent Securing Novel Compound Library for Mental Health Breakthroughs

Psilera Receives Allowance on Flagship Patent Securing Novel Compound Library for Mental Health Breakthroughs
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesKatie demarshChris witowskiTrademark officeUnited states patentPharmaceutical compositionsPsilera third eye

Psilera Unveils Novel, Non-Hallucinogenic Psilocybin Derivative PSIL-006 As Lead Clinical Candidate

/PRNewswire/ Psilera, a biopharmaceutical company developing next-generation mental health treatments for take home use, announces the selection of their.

Katie demarshChris witowski